Cutler Group LP
- SEC CIK
- 0001534270
- Latest filing
- Apr 19, 2024
APLS holding history
Apellis Pharmaceuticals, Inc. in every 13F filed by Cutler Group LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APLS overviewAll 13F holders of APLSFull Q1 2024 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −10,201−100.0% | Sold out | Holders |
| Q4 2023 | 10,201 | $610.0K | 0.1% | −26,921−72.5% | Reduced | Holders |
| Q3 2023 | 37,122 | $1.41M | 0.2% | +36,343+4,665.3% | Added | Holders |
| Q2 2023 | 779 | $70.0K | <0.1% | −2,721−77.7% | Reduced | Holders |
| Q1 2023 | 3,500 | $230.0K | <0.1% | +3,225+1,172.7% | Added | Holders |
| Q4 2022 | 275 | $14.0K | <0.1% | +175+175.0% | Added | Holders |
| Q3 2022 | 100 | $6.00K | <0.1% | −10,363−99.0% | Reduced | Holders |
| Q2 2022 | 10,463 | $473.0K | 0.1% | +8,200+362.4% | Added | Holders |
| Q1 2022 | 2,263 | $114.0K | <0.1% | −3,030−57.2% | Reduced | Holders |
| Q4 2021 | 5,293 | $250.0K | <0.1% | −96,492−94.8% | Reduced | Holders |
| Q3 2021 | 101,785 | $3.35M | 0.3% | +98,985+3,535.2% | Added | Holders |
| Q2 2021 | 2,800 | $176.0K | <0.1% | +2,000+250.0% | Added | Holders |
| Q1 2021 | 800 | $34.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.